FMC - Brunswick Dialysis Center is a medicare approved dialysis facility center in Hinckley, Ohio and it has 19 dialysis stations. It is located in Medina county at 2583-2585 Center Road, Hinckley, OH, 44233. You can reach out to the office of FMC - Brunswick Dialysis Center at (330) 220-4366. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Brunswick Dialysis Center has the following ownership type - Profit. It was first certified by medicare in November, 2004. The medicare id for this facility is 362763 and it accepts patients under medicare ESRD program.
| Name | FMC - Brunswick Dialysis Center |
|---|---|
| Location | 2583-2585 Center Road, Hinckley, Ohio |
| No. of Dialysis Stations | 19 |
| Medicare ID | 362763 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2583-2585 Center Road, Hinckley, Ohio, 44233 | |
| (330) 220-4366 | |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
| NPI Number | 1356457295 |
| Organization Name | Fresenius Medical Care Of Brunswick |
| Doing Business As | Bio-medical Applications Of Ohio, Inc. |
| Address | 2583/2585 Center Rd. Hinckley, Ohio, 44233 |
| Phone Number | (330) 220-4366 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 8 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 20 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 178 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
| Adult patients getting regular peritoneal dialysis at the center | 8 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 36 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Brunswick Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 30 |
| Hypercalcemia patient months | 241 |
| Patients with Serumphosphor | 31 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 21 |
| Patient months included in arterial venous fistula and catheter summaries | 107 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 50 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 21 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 29 |
| Hospitalization Rate in facility | 393.8 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 676.6 |
| Hospitalization Rate: Lower Confidence Limit | 239.1 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Brunswick Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 35 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 47.1 |
| Readmission Rate: Lower Confidence Limit | 23.9 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC - Brunswick Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .6 (As Expected) |
| SIR: Upper Confidence Limit | 2.94 |
| SIR: Lower Confidence Limit | .03 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC - Brunswick Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 22 |
| Transfusion Rate in facility | (Not Available) |
| Transfusion Rate: Upper Confidence Limit | |
| Transfusion Rate: Lower Confidence Limit |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC - Brunswick Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 179 |
| Mortality Rate in facility | 18.5 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 26 |
| Mortality Rate: Lower Confidence Limit | 12.8 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago
FMC - Brunswick Dialysis Center Location: 2583-2585 Center Road, Hinckley, Ohio, 44233 Phone: (330) 220-4366 |
News Archive
AmpliPhi's commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Each year, the holiday season brings good tidings and cheer along with an abundance of sweet treats, from tasty eggnog to candy canes. The holiday food frenzy actually begins with Halloween candy and lingers all the way until the big game, offering a steady stream of tempting goodies that can be a real hazard for the millions of people living with diabetes or at risk for diabetes.
› Verified 8 days ago